Imunon (IMNN) Stock Price
Imunon Price
Revenue at Imunon has contracted by 23.3% per year over the past 17 years to 125,000.00 USD. For Imunon, the net margin of -15,612.0% is down versus -3,370.3% a few years ago.
Imunon stock price
Imunon business model & stock analysis
Frequently asked questions about Imunon
10 analysts currently rate the Imunon stock: 9 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Imunon share trades at 1.02 EUR (1.14 USD).
The Imunon share (IMNN) is listed on 6 stock exchanges, including: NASDAQ (CLSN), London (0HUZ.L), Frankfurt (CBO.F), München (CBO.MU), Düsseldorf (CBO.DU).
The revenue cannot currently be calculated for Imunon.
The expected profit of Imunon is -7.17 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Imunon is currently -0.34. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Imunon stock.
The P/S cannot be calculated for Imunon currently.
The Eulerpool Quality Score for Imunon is 2/10.
The ISIN of Imunon is US15117N7012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Imunon is A3DWEJ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Imunon is IMNN. The ticker symbol is used to trade Imunon shares on the stock exchange.
Imunon stock
Imunon Peer Group
Imunon Ticker
All fundamentals and in-depth analysis of Imunon
Our stock analysis for Imunon stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Imunon. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.